Christopher R. Stone

Array ( [id] => 10844570 [patent_doc_number] => 08871747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Urea and thiourea derivatives' [patent_app_type] => utility [patent_app_number] => 13/060789 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19807 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5394228 [patent_doc_number] => 20090314290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'DRUG DELIVERY IN ASSOCIATION WITH MEDICAL OR SURGICAL PROCEDURES' [patent_app_type] => utility [patent_app_number] => 12/511858 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19980 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0314/20090314290.pdf [firstpage_image] =>[orig_patent_app_number] => 12511858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591546 [patent_doc_number] => 20100130520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/501599 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15918 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130520.pdf [firstpage_image] =>[orig_patent_app_number] => 12501599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590913 [patent_doc_number] => 20100130493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'COMBINATION OF VEGF RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/501593 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7215 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130493.pdf [firstpage_image] =>[orig_patent_app_number] => 12501593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302293 [patent_doc_number] => 20100068197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/500449 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25556 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068197.pdf [firstpage_image] =>[orig_patent_app_number] => 12500449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494552 [patent_doc_number] => 20100093756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/499370 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14229 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093756.pdf [firstpage_image] =>[orig_patent_app_number] => 12499370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629901 [patent_doc_number] => 20100004302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Methods for Treating Degenerative Diseases/Injuries' [patent_app_type] => utility [patent_app_number] => 12/496867 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12554 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004302.pdf [firstpage_image] =>[orig_patent_app_number] => 12496867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628387 [patent_doc_number] => 20100004217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'TOPICAL STEROIDAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/494928 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26597 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004217.pdf [firstpage_image] =>[orig_patent_app_number] => 12494928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6624901 [patent_doc_number] => 20100034796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction' [patent_app_type] => utility [patent_app_number] => 12/459227 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3388 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034796.pdf [firstpage_image] =>[orig_patent_app_number] => 12459227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636841 [patent_doc_number] => 20100035862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/490569 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38164 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035862.pdf [firstpage_image] =>[orig_patent_app_number] => 12490569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421806 [patent_doc_number] => 08278294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase' [patent_app_type] => utility [patent_app_number] => 12/487403 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19373 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12487403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374777 [patent_doc_number] => 20090312338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Novel Tricyclic Compounds' [patent_app_type] => utility [patent_app_number] => 12/481028 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136479 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312338.pdf [firstpage_image] =>[orig_patent_app_number] => 12481028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5303527 [patent_doc_number] => 20090298179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Methods For Treating Degenerative Diseases/Injuries' [patent_app_type] => utility [patent_app_number] => 12/474560 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12319 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298179.pdf [firstpage_image] =>[orig_patent_app_number] => 12474560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320597 [patent_doc_number] => 20100113398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Treatment and/or Prevention of Non-Viral Epithelial Damage' [patent_app_type] => utility [patent_app_number] => 12/469259 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15198 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113398.pdf [firstpage_image] =>[orig_patent_app_number] => 12469259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580952 [patent_doc_number] => 20110294835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Muscarinic Agonists as Cognitive Enhancers' [patent_app_type] => utility [patent_app_number] => 12/992709 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10901 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 63 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294835.pdf [firstpage_image] =>[orig_patent_app_number] => 12992709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539853 [patent_doc_number] => 20090221658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Pharmacological Treatment for Sleep Apnea' [patent_app_type] => utility [patent_app_number] => 12/465186 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10786 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221658.pdf [firstpage_image] =>[orig_patent_app_number] => 12465186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539896 [patent_doc_number] => 20090221701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure' [patent_app_type] => utility [patent_app_number] => 12/453470 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1969 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221701.pdf [firstpage_image] =>[orig_patent_app_number] => 12453470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515591 [patent_doc_number] => 20090215898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'TRANEXAMIC ACID FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/433408 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18679 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215898.pdf [firstpage_image] =>[orig_patent_app_number] => 12433408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644500 [patent_doc_number] => 08022106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Tranexamic acid formulations' [patent_app_type] => utility [patent_app_number] => 12/433510 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 32269 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022106.pdf [firstpage_image] =>[orig_patent_app_number] => 12433510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485841 [patent_doc_number] => 20090275606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Heterocyclic Compounds as MEK Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/427137 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53346 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275606.pdf [firstpage_image] =>[orig_patent_app_number] => 12427137 [rel_patent_id] =>[rel_patent_doc_number] =>)